Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PL✓SelectedUSD · PLGSK vs PL performance historyLatest closeAs of-0.60%11/10
Stock and ETF performance explorer

GSK vs PL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+45.3%
PL return
+36.0%
Excess return
+9.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioPLExcessAlpha
1D-0.6%-0.7%+0.1%-0.6%
7D+5.2%+5.6%-0.4%+5.1%
30D+10.2%-16.9%+27.1%+10.3%
3M-0.9%-38.2%+37.3%-0.6%
6M+3.5%-63.4%+66.9%+4.2%
YTD+7.2%-27.6%+34.9%+7.2%
1Y+12.0%+6.6%+5.4%+11.3%
3Y+67.3%+557.6%-490.3%+59.7%
5Y+45.3%+39.5%+5.8%+41.0%
All+45.3%+36.0%+9.2%+41.0%

Cumulative growth

Daily Returns

Daily percentage return beside PL.

Daily Out/Under-Performance

Portfolio return minus PL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded PL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling